4/9/2013

Among U.S. states, Texas ranks second in clinical trials, but greater public awareness is needed to help increase patient participation. "We're trying to get the word out because so many trials don't have enough patients. That can slow drug development," PhRMA spokesman Jeff Trewhitt said.

Related Summaries